Justin Schreiber
Chief Executive Officer at LifeMD Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: LifeMD Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
LifeMD Inc. June 13, 202597.8%
-
LifeMD Inc. June 16, 202392.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2025 | LifeMD Inc. | Open-market sale | −25,000 | $9.99 | $249,750 |
| Jul 1, 2025 | LifeMD Inc. | Open-market sale | −25,000 | $13.38 | $334,500 |
| Jun 2, 2025 | LifeMD Inc. | Open-market sale | −25,000 | $12.47 | $311,750 |
| May 2, 2025 | LifeMD Inc. | Open-market sale | −3,005 | $7.50 | $22,538 |
| May 1, 2025 | LifeMD Inc. | Open-market sale | −21,995 | $7.53 | $165,622 |
| Apr 29, 2025 | LifeMD Inc. | Open-market sale | −50,000 | $7.78 | $389,000 |
| Mar 19, 2025 | LifeMD Inc. | Gift | −27,994 | — | — |
| Mar 19, 2025 | LifeMD Inc. | Gift | +13,997 | — | — |
| Mar 19, 2025 | LifeMD Inc. | Gift | +13,997 | — | — |
| Feb 14, 2025 | LifeMD Inc. | Open-market sale | −50,000 | $7.55 | $377,500 |
| Jan 2, 2025 | LifeMD Inc. | Open-market sale | −25,000 | $5.19 | $129,750 |
| Dec 2, 2024 | LifeMD Inc. | Open-market sale | −25,000 | $6.52 | $163,000 |
| Dec 2, 2024 | LifeMD Inc. | Other | +0 | — | — |
Questions about Justin Schreiber
What boards is Justin Schreiber on?
Justin Schreiber sits on the board of LifeMD Inc.
What company is Justin Schreiber the CEO of?
Justin Schreiber is Chief Executive Officer of LifeMD Inc.
How long has Justin Schreiber served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.